PEREGRINE PHARMACEUTICALS INC 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Jun 3, 2016
Insider Transaction Report
Form 4
LYTLE PAUL J
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-06-02+250,000→ 1,547,500 totalExercise: $0.50From: 2016-09-02Exp: 2026-06-02→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]This option vests in eight (8) equal quarterly installments over a two (2) year period beginning September 2, 2016 and each quarter thereafter until fully-vested.